
As the psychedelics space gains traction on many levels, a number of studies are being conducted to examine whether psychedelic medications can or should be used to treat depression in cancer patients.
Over the years, the U.S. Food and Drug Administration (FDA) even designated a number of psilocybin trials as "breakthrough therapies" for treating severe depression, New Atlas wrote.